The business with weight: Weight loss injection: Will people in Germany eat less soon?
If soon millions of people have less hunger, will shopping and consumer behavior also change? Answers to the most important questions.
Novo Nordisk, a Danish pharmaceutical company, has seen significant growth due to its weight loss medications, Ozempic and Wegovy. The company's competitor, US-based Eli Lilly, is currently the world's most valuable healthcare company. As millions of people begin using these medications, which contain the active ingredient Semaglutid, the food industry is bracing for potential changes in consumer behavior.
According to a YouGov study, 1.7 million households in Germany with at least one GLP-1 user reduced their grocery purchases by 3% more than households without users, potentially resulting in a €325 million annual loss in sales.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
